Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | USPH | Common Stock | Sale | -$142K | -1.72K | -19.68% | $82.50 | 7.04K | Aug 21, 2024 | Reeve Trust | F1 |
holding | USPH | Common Stock | 14.7K | Aug 21, 2024 | Direct | F2 |
Id | Content |
---|---|
F1 | The reported price is the weighted average price. The reporting person undertakes to provide to U.S. Physical Therapy Inc., any of its shareholders or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold each at each separate price on this footnote Form 4. |
F2 | Includes 14,676 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 1,792 shares on October 1, 2024; 1,793 shares on January 1, 2025, 1,442 shares on April 1, 2025, July 1, 2025, October 1, 2025; 1,459 shares on January 1, 2026; 818 shares on April 1, 2026, July 1, 2026, October 1, 2026; 827 shares on January 1, 2027; and 506 shares on each of April 1, 2027, July 1, 2027, October 1, 2027 and 507 shares on January 2028, if he is a director of the Company on those dates. |